Literature DB >> 22823910

Discovery of ligands for ADP-ribosyltransferases via docking-based virtual screening.

C David Andersson1, Tobias Karlberg, Torun Ekblad, Anders E G Lindgren, Ann-Gerd Thorsell, Sara Spjut, Urszula Uciechowska, Moritz S Niemiec, Pernilla Wittung-Stafshede, Johan Weigelt, Mikael Elofsson, Herwig Schüler, Anna Linusson.   

Abstract

The diphtheria toxin-like ADP-ribosyltransferases (ARTDs) are an enzyme family that catalyzes the transfer of ADP-ribose units onto substrate proteins by using nicotinamide adenine dinucleotide (NAD(+)) as a cosubstrate. They have a documented role in chromatin remodelling and DNA repair, and inhibitors of ARTD1 and 2 (PARP1 and 2) are currently in clinical trials for the treatment of cancer. The detailed function of most other ARTDs is still unknown. By using virtual screening, we identified small ligands of ARTD7 (PARP15/BAL3) and ARTD8 (PARP14/BAL2). Thermal-shift assays confirmed that 16 compounds, belonging to eight structural classes, bound to ARTD7/ARTD8. Affinity measurements with isothermal titration calorimetry for two isomers of the most promising hit compound confirmed binding in the low micromolar range to ARTD8. Crystal structures showed anchoring of the hits in the nicotinamide pocket. These results form a starting point in the development of chemical tools for the study of the role and function of ARTD7 and ARTD8.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22823910     DOI: 10.1021/jm300746d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein.

Authors:  Tobias Karlberg; Mirjam Klepsch; Ann-Gerd Thorsell; C David Andersson; Anna Linusson; Herwig Schüler
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 3.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

4.  Rational design of selective inhibitors of PARP4.

Authors:  Ilsa T Kirby; Ashley Person; Michael Cohen
Journal:  RSC Med Chem       Date:  2021-10-04

Review 5.  PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis.

Authors:  Marie-France Langelier; John M Pascal
Journal:  Curr Opin Struct Biol       Date:  2013-01-16       Impact factor: 6.809

6.  A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases.

Authors:  Jingwen Chen; Albert T Lam; Yong Zhang
Journal:  Anal Biochem       Date:  2017-12-13       Impact factor: 3.365

Review 7.  Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives.

Authors:  Palmiro Poltronieri; Angela Celetti; Luca Palazzo
Journal:  Cells       Date:  2021-01-11       Impact factor: 6.600

Review 8.  Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling.

Authors:  Tobias Karlberg; Marie-France Langelier; John M Pascal; Herwig Schüler
Journal:  Mol Aspects Med       Date:  2013-02-28

9.  DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.

Authors:  Samia B Bachmann; Sandra C Frommel; Rosalba Camicia; Hans C Winkler; Raffaella Santoro; Paul O Hassa
Journal:  Mol Cancer       Date:  2014-05-27       Impact factor: 27.401

10.  Structural basis for the inhibition of poly(ADP-ribose) polymerases 1 and 2 by BMN 673, a potent inhibitor derived from dihydropyridophthalazinone.

Authors:  Mika Aoyagi-Scharber; Anna S Gardberg; Bryan K Yip; Bing Wang; Yuqiao Shen; Paul A Fitzpatrick
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-08-29       Impact factor: 1.056

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.